Lathers DM - Search Results

1

Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapy.

Wiers KM, Lathers DM, Wright MA, Young MR. Wiers KM, et al. Among authors: lathers dm. J Immunother. 2000 Jan;23(1):115-24. doi: 10.1097/00002371-200001000-00014. J Immunother. 2000. PMID: 10687144

2

Increased resistance to apoptosis by bone marrow CD34(+)progenitor cells from tumor-bearing mice.

Young MR, Wright MA, Lathers DM, Messingham KA. Young MR, et al. Among authors: lathers dm. Int J Cancer. 1999 Aug 12;82(4):609-15. doi: 10.1002/(sici)1097-0215(19990812)82:4<609::aid-ijc23>3.0.co;2-a. Int J Cancer. 1999. PMID: 10404079

3

CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancer.

Pandit R, Lathers DM, Beal NM, Garrity T, Young MR. Pandit R, et al. Among authors: lathers dm. Ann Otol Rhinol Laryngol. 2000 Aug;109(8 Pt 1):749-54. doi: 10.1177/000348940010900809. Ann Otol Rhinol Laryngol. 2000. PMID: 10961808

4

Impact of aging on immune modulation by tumor.

Young MR, Kolesiak K, Achille NJ, Meisinger J, Gonzalez E, Liu SW, Wrone-Smith T, Lathers DM. Young MR, et al. Among authors: lathers dm. Cancer Immunol Immunother. 2001 Aug;50(6):315-20. doi: 10.1007/s002620100203. Cancer Immunol Immunother. 2001. PMID: 11570585 Free PMC article.

5

Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients.

Lathers DM, Clark JI, Achille NJ, Young MR. Lathers DM, et al. Hum Immunol. 2001 Nov;62(11):1282-93. doi: 10.1016/s0198-8859(01)00317-2. Hum Immunol. 2001. PMID: 11704292 Clinical Trial.

6

Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1alpha,25-dihydroxyvitamin D3.

Young MR, Wright MA, Vellody K, Lathers DM. Young MR, et al. Among authors: lathers dm. Int J Immunopharmacol. 1999 Oct;21(10):675-88. doi: 10.1016/s0192-0561(99)00044-2. Int J Immunopharmacol. 1999. PMID: 12609462

7

Dendritic cell development from mobilized peripheral blood CD34+ cells.

Lathers DM, Achille N, Young MR. Lathers DM, et al. Methods Mol Biol. 2003;215:409-15. doi: 10.1385/1-59259-345-3:409. Methods Mol Biol. 2003. PMID: 12512316 No abstract available.

8

Phase 1B study to improve immune responses in head and neck cancer patients using escalating doses of 25-hydroxyvitamin D3.

Lathers DM, Clark JI, Achille NJ, Young MR. Lathers DM, et al. Cancer Immunol Immunother. 2004 May;53(5):422-30. doi: 10.1007/s00262-003-0459-7. Epub 2003 Nov 26. Cancer Immunol Immunother. 2004. PMID: 14648070 Free PMC article. Clinical Trial.

9

Decreased T-cell proliferation and skewed immune responses in LLC-bearing mice.

Rashid RM, Achille NJ, Lee JM, Lathers DM, Young MR. Rashid RM, et al. Among authors: lathers dm. J Environ Pathol Toxicol Oncol. 2005;24(3):175-92. doi: 10.1615/jenvpathtoxoncol.v24.i3.40. J Environ Pathol Toxicol Oncol. 2005. PMID: 16050802

10

Combination docetaxel plus vitamin D(3) as an immune therapy in animals bearing squamous cell carcinomas.

Young MR, Lathers DM. Young MR, et al. Among authors: lathers dm. Otolaryngol Head Neck Surg. 2005 Oct;133(4):611-8. doi: 10.1016/j.otohns.2005.05.658. Otolaryngol Head Neck Surg. 2005. PMID: 16213938

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters